Iron Oxide-Gold Core-Shell Nanoparticles as Multimodal Imaging Contrast Agent

Nanoparticles (NPs) are emerging as a potential medical tool for novel diagnostic, drug delivery, and therapeutic approaches. Among them, a spherical NP with a core-shell structure is a way to combine multiple functionalities on the nanoscale. In this paper, we describe the preparation characterization and applications of core-shell iron oxide-gold nanoparticles (<formula formulatype="inline"><tex Notation="TeX">${\rm Fe}_{3}{\rm O}_{4}$</tex></formula>@Au NPs). A comprehensive set of experiments, including transmission electron microscopy, dynamic light scattering, small angle neutron scattering, and ultraviolet visible spectroscopy is applied to characterize their chemical, physical, and optical properties. We also study their applicability as contrast agents for magnetic resonance imaging (MRI): the measurement of longitudinal and transverse relaxation times of <formula formulatype="inline"><tex Notation="TeX">${\rm Fe}_{3}{\rm O}_{4}$</tex></formula>@Au NPs in vitro and in vivo allowed the assessment of longitudinal <formula formulatype="inline"><tex Notation="TeX">$({\rm R}_{1})$</tex></formula> and transverse <formula formulatype="inline"> <tex Notation="TeX">$({\rm R}_{2})$</tex></formula> relaxivities at 1.5 and 3 T. Finally, a procedure for functionalizing NPs with integrin targeting cyclic Arginine-Glycine-Aspartate peptidomimetic is reported, leading to the development of nanoscale probes for <formula formulatype="inline"><tex Notation="TeX">$\alpha_{v}\beta_{3}$</tex></formula> integrin, particularly attractive in terms of resolution and 3-D imaging capabilities. The resulting multifunctional nanoprobes offer suitable blood-circulation time and contrast for microimaging as well as for gradient-echo MRI, and could enable new imaging magnetoplasmonic applications.

[1]  Thomas D. Coates,et al.  Cardiac Iron Determines Cardiac T2*, T2, and T1 in the Gerbil Model of Iron Cardiomyopathy , 2005, Circulation.

[2]  Elodie Boisselier,et al.  Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. , 2009, Chemical Society reviews.

[3]  G. Alghisi,et al.  Vascular integrins in tumor angiogenesis: mediators and therapeutic targets. , 2006, Endothelium : journal of endothelial cell research.

[4]  Francesco Conversano,et al.  Magnetic/Silica Nanocomposites as Dual‐Mode Contrast Agents for Combined Magnetic Resonance Imaging and Ultrasonography , 2011 .

[5]  B. Simard,et al.  Laser-assisted synthesis of superparamagnetic Fe@Au core-shell nanoparticles. , 2006, The journal of physical chemistry. B.

[6]  Carlo Scolastico,et al.  Cyclic RGD functionalized gold nanoparticles for tumor targeting. , 2011, Bioconjugate chemistry.

[7]  Priyabrata Mukherjee,et al.  Gold nanoparticles: opportunities and challenges in nanomedicine , 2010, Expert opinion on drug delivery.

[8]  M. O’Donnell,et al.  Multifunctional nanoparticles as coupled contrast agents. , 2010, Nature communications.

[9]  A. Menciassi,et al.  Boron Nitride Nanotubes as T 2 -Weighted MRI Contrast Agents , 2010 .

[10]  V. Pierre,et al.  Fe3O4@organic@Au: core-shell nanocomposites with high saturation magnetisation as magnetoplasmonic MRI contrast agents. , 2011, Chemical communications.

[11]  G. Fournet,et al.  Small‐Angle Scattering of X‐Rays , 1956 .

[12]  Jin Luo,et al.  Monodispersed core-shell Fe3O4@Au nanoparticles. , 2005, The journal of physical chemistry. B.

[13]  A. Menciassi,et al.  Boron nitride nanotubes for boron neutron capture therapy as contrast agents in magnetic resonance imaging at 3 T. , 2011, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[14]  C. Robic,et al.  Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. , 2008, Chemical reviews.

[15]  M. Civera,et al.  Cyclic RGD‐Containing Functionalized Azabicycloalkane Peptides as Potent Integrin Antagonists for Tumor Targeting , 2009, ChemMedChem.

[16]  Xin Wang,et al.  Gold and magnetic oxide/gold core/shell nanoparticles as bio-functional nanoprobes , 2008, Nanotechnology.

[17]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.

[18]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.

[19]  Aimé Lay-Ekuakille,et al.  Harmonic Ultrasound Imaging of Nanosized Contrast Agents for Multimodal Molecular Diagnoses , 2012, IEEE Transactions on Instrumentation and Measurement.

[20]  M. El-Sayed,et al.  Spectral Properties and Relaxation Dynamics of Surface Plasmon Electronic Oscillations in Gold and Silver Nanodots and Nanorods , 1999 .

[21]  V. Novosad,et al.  Synthesis of Hybrid Gold/Iron Oxide Nanoparticles in Block Copolymer Micelles for Imaging, Drug Delivery, and Magnetic Hyperthermia , 2009, IEEE Transactions on Magnetics.

[22]  M. Morita,et al.  Simple PEG conjugation of SPIO via an Au-S bond improves its tumor targeting potency as a novel MR tumor imaging agent. , 2010, Bioconjugate chemistry.

[23]  R. Ramanujan,et al.  Anti-cancer drug loaded iron-gold core-shell nanoparticles (Fe@Au) for magnetic drug targeting. , 2010, Journal of nanoscience and nanotechnology.

[24]  Zhichuan J. Xu,et al.  Magnetic core/shell Fe3O4/Au and Fe3O4/Au/Ag nanoparticles with tunable plasmonic properties. , 2007, Journal of the American Chemical Society.

[25]  M. Kano,et al.  Enhanced in vivo Magnetic Resonance Imaging of Tumors by PEGylated Iron-Oxide-Gold Core-Shell Nanoparticles with Prolonged Blood Circulation Properties. , 2010, Macromolecular rapid communications.

[26]  F. Bates,et al.  Absolute calibration of small‐angle neutron scattering data , 1987 .

[27]  D. Astruc,et al.  Applications of vectorized gold nanoparticles to the diagnosis and therapy of cancer. , 2012, Chemical Society reviews.